Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
| ▸ | MAOB | P27338 | 1/20 | 0.59 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.53 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | CA7 | P43166 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.51 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9402555 | 1.00 | MAOA (0.59) | MAOAMAOBPTPN11SMPD1CA12 | |
| SCHEMBL4654884 | 1.00 | MAOA (0.59) | MAOAMAOBPTPN11SMPD1CA12 | |
| SCHEMBL9698412 | 1.00 | MAOA (0.59) | MAOAMAOBPTPN11SMPD1CA12 | |
| SCHEMBL12587312 | 0.96 | CA12 (0.56) | MAOAMAOBPTPN11CA12CA1 | |
| SCHEMBL1318263 | 0.90 | CA12 (0.56) | MAOAMAOBCA12CA1CA2 | |
| SCHEMBL4652377 | 0.89 | MAOB (0.59) | MAOAMAOBCA12CA1CA2 | |
| SCHEMBL4653766 | 0.89 | MAOB (0.59) | MAOAMAOBCA12CA1CA2 | |
| SCHEMBL22438932 | 0.89 | MAOB (0.59) | MAOAMAOBCA12CA1CA2 | |
| SCHEMBL9324807 | 0.89 | MAOB (0.59) | MAOAMAOBCA12CA1CA2 | |
| SCHEMBL26331429 | 0.89 | CA12 (0.51) | MAOAMAOBPTPN11CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5374772-A | Skin disorders, antiinflammatory agents, cardiovascular disorders | HOFFMANN-LAROCHE INC. (US) | 1994-12-20 | — | — | US | disclosed |
| EP-0601385-A1 | Disubstituted benzoic acid derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1994-06-15 | — | — | EP | disclosed |
| US-5298652-A | N-substituted glycines, inhibitors of phospholipase A2 | HOFFMANN-LA ROCHE INC. (US) | 1994-03-29 | — | — | US | disclosed |